Wieslab 盒子
Wieslab designs, manufactures and sells diagnostic kits for autoimmune
diseases, cartilage markers and Alport syndrome.
Wieslab are world leaders in diagnosis of autoimmune vasculitic
disorders and were the first to develop commercial ELISA-tests for anti-GBM
and PR3-ANCA.
Wieslab's line of kits include:
- 定量的 ELISA assays for determining levels of autoantibodies
towards ANCA and GBM antigens as well as dsDNA and ASCA
- 定性的 ELISA assays for determining the presence autoantibodies
towards ANCA and GBM antigens
- 软骨 markers. A new line of assays for quantitating the cartilage
protein COMP and sulphated glycosaminoglycans
- Miscellaneous kits.
Alport syndrome diagnosis and PIZ mutation detection.
- Complement System.
A new line of assays employing ELISA technology to screen for deficiencies
in the three pathways of the complement system. Our first product covers
the Classical, Alternative and Mannose Binding Lectin pathways.
| Prod.no |
Description |
| PR3 102 |
PR3-ANCA. Proteinase 3-ANCA |
| Cap-PR3 |
Capture PR3-ANCA. Proteinase
3-ANCA in capture format |
| MPO 103 |
MPO-ANCA. Myeloperoxidase-ANCA
detection |
| GP 104 |
Anti-GBM antibody. Anti-Glomerular
Basement Membrane antibodies directed against the NC1 domain of
Collagen IV |
| BPI 107 |
BPI-ANCA. Bactericidal Permeability
Increasing Protein-ANCA |
| DNA 109 |
Anti-ds-DNA. Anti double stranded
DNA antibodies |
| ASCA 150 |
ASCA IgA. Anti Saccharomyces
Cerevisiae IgA-class antibody. |
| ASCA 151 |
ASCA IgG. Anti Saccharomyces
Cerevisiae IgG-class antibody. |
| B2GP1 120 |
Beta-2-Glycoprotein 1 IgG.
Anti b2GP1 IgG-class antibody |
| B2GP1 121 |
Beta-2-Glycoprotein 1 IgM.
Anti b2GP1 IgM-class antibody |
| Prod.no |
Description |
| GCP 100 |
Anti-GBM and ANCA rapid screening. |
| CP 101 |
ANCA rapid screening. Detection of autoantibodies
against PR3 and MPO. |
| PR3 112 |
PR3-ANCA rapid screening. |
| MPO 113 |
MPO-ANCA rapid screening. |
| GP 114 |
Anti-GBM antibodies rapid screening. |
| PAN 116 |
ANCA panel screening for detection of autoantibodies
against azurocidin, BPI, cathepsin G, elastase, lactoferrin and
lysozyme. |
| AZU
117 |
Azurocidin-ANCA. |
| EL
115 |
Elastase-ANCA. |
| CAT
116 |
Cathepsin G-ANCA. |
| Prod.no |
Description |
| COMP200 |
hCOMP. ELISA for quantification of human
COMP (Cartilage Oligomeric Matrix Protein) |
| GAG 201 |
sGAG. Alcian blue-binding assay for detection
and quantification of sulfated glycosaminoglycans. |
| Prod.no |
Description |
| ALP 105 |
Alport syndrome kit. Immunofluorescence
kit utilising three monoclonal antibodies to the alfa1, alfa3
and alfa5 chains of Collagen IV. For help in the diagnosis of
Alport Syndrome on kidney and skin biopsies |
| PIZ 210 |
AAT deficiency test. ELISA
kit for qualitative determination of of the presence of the Z-form
of alfa-1-antitrypsin (AAT) |
| Prod.no |
Description |
| COMPL 300 |
Total Complement System Screen.
Functional assay for the three complement pathways (Classical,
Lectin and Alternative) employing ELISA technology. |
|
